SHANGHAI: A new stock market index focused on biopharmaceutical equities will launch on May 9 and is expected to facilitate innovation in the industry, besides spurring high-quality development in the country, experts said.
The Shanghai Stock Exchange (SSE) and China Securities Index Co Ltd jointly announced on Tuesday that the Star Market Biology and Medicine Index will include 50 large-cap biopharmaceutical companies listed on the Star Market, which is part of the Shanghai bourse.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
